AI assistant
VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2014
Oct 23, 2014
29864_dirs_2014-10-23_5dcfa7e5-39f6-44a7-b275-308af49eb671.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2014-10-22
Reporting Person: BOGER JOSHUA S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-10-22 | Common Stock | M | 4800 | $10.41 | Acquired | 343695 | Direct |
| 2014-10-22 | Common Stock | M | 1300 | $17.16 | Acquired | 344995 | Direct |
| 2014-10-22 | Common Stock | M | 4400 | $35.64 | Acquired | 349395 | Direct |
| 2014-10-22 | Common Stock | S | 5400 | $106.83 | Disposed | 343995 | Direct |
| 2014-10-22 | Common Stock | S | 1600 | $107.49 | Disposed | 342395 | Direct |
| 2014-10-22 | Common Stock | S | 2800 | $108.87 | Disposed | 339595 | Direct |
| 2014-10-22 | Common Stock | S | 700 | $109.82 | Disposed | 338895 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-10-22 | Stock Option (right to buy) | $10.41 | M | 4800 | Disposed | 2015-02-02 | Common Stock (4800) | Direct |
| 2014-10-22 | Stock Option (right to buy) | $17.16 | M | 1300 | Disposed | 2015-07-19 | Common Stock (1300) | Direct |
| 2014-10-22 | Stock Option (right to buy) | $35.64 | M | 4400 | Disposed | 2016-02-01 | Common Stock (4400) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 13286 | Indirect |
| Common Stock | 300000 | Indirect |
Footnotes
F1: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
F2: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3: Open market sales reported on this line occurred at a weighted average price of $106.83 (range $106.21 to $107.20).
F4: Open market sales reported on this line occurred at a weighted average price of $107.49 (range $107.22 to $108.16).
F5: Open market sales reported on this line occurred at a weighted average price of $108.87 (range $108.44 to $109.36).
F6: Open market sales reported on this line occurred at a weighted average price of $109.82 (range $109.57 to $110.49).
F7: Common stock held in grantor retained annuity trusts.
F8: Fully vested.